Neonatal Intensive Care Unit (NICU) of Alexandria University Maternity Hospital.
Alexandria, 0356, Egypt
NCT Number: NCT05706428
The aim of the present work is to study the cardio-respiratory effects of non-invasive ventilation (nasal high-frequency ventilation and nasal CPAP) as an initial therapy of respiratory distress in moderate and late preterm infants as regard:
I. Primary outcomes:
* Duration of the non- invasive respiratory support. * Need of invasive ventilation in the first 72 hours. * Short-term complications such as air leak syndromes, pulmonary hemorrhage, intraventricular hemorrhage, and nasal trauma.
II. Secondary outcomes:
* Need for surfactant administration. * Days on invasive mechanical ventilation. * Days on supplemental oxygen. * Duration of hospital stay. * Mortality rate. III. Hemodynamic changes during the period of non-invasive ventilation.
Looking for future studies?
Notify Me1 hour–3 day
All sexes
Interventional
Not applicable
Alexandria, 0356, Egypt
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Moderate and late preterm infants born between 32+0 to 36+6 weeks gestation(according to WHO definitions of preterm birth) admitted to the neonatal intensive care unit with spontaneous breathing and clinical manifestations of RD (tachypnea, nasal flaring, intercostal and subcostal retraction and or grunting).
Exclusion criteria
The neonate patients with respiratory distress will have nasal high frequency ventilation as an initial mode of respiratory support.
The neonate patients with respiratory distress will have nasal continuous positive airway pressure as an initial mode of respiratory support.
Time frame: first 3 days of life
The SVC diameter will be visualized from a high parasternal long axis view. The maximum and minimum internal diameters will be then measured. ✓ The SVC flow velocity will be visualized from a low subcostal view and the pulsed Doppler recording will be made at the junction of the SVC and the right atrium. ✓ SVC flow will be calculated using the method described by Kluckow and Evans:(27) SVC flow (ml/kg/min) = [VTI (cm/beat) × 3.14 × (mean SVC diameter2
/4) × heart rate (beat/min)] Body weight in kg 11
Time frame: first 3 days of life
CSA (cm) (Cross sectional area of PV by long axis parasternal RV outflow view - 2D - immediately beneath pulmonary annulus
Time frame: first 3 days of life
CSA (cm) (Cross sectional area of AV by long axis parasternal view - 2D - immediately beneath aortic annulus - mid- systole - inner edge to inner edge) = π x (radius) 2 . ✓ VTI (cm) (Velocity Time Integral or Stroke Distance = Distance over which blood travels in once cardiac cycle → Apical 5- chamber view). ✓ SV (ml/beat) (Stroke Volume = CSA x VTI). ✓ Output (L/min.) COP = SV x HR
Time frame: first 3 days of life
Trans-frontellar cranial sonography using Doppler study
Alexandria University
Other
Cardiorespiratory Effects of Nasal High Frequency Ventilation in Moderate and Late Preterm Infants With Respiratory Distress
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05987800
Bronchopulmonary Dysplasia, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Jette, Brussels Capital, Belgium
View Trial DetailsNCT03388437
Bronchopulmonary Dysplasia, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Jeddah, Saudi Arabia
View Trial DetailsNCT04068558
Bronchopulmonary Dysplasia, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Créteil, France
View Trial DetailsNCT04659083
Bronchopulmonary Dysplasia, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Turku, Finland
View Trial Details